Insulin glargine and lixisenatide and Mycophenolate mofetil oral/injection
Determining the interaction of Insulin glargine and lixisenatide and Mycophenolate mofetil oral/injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: mycophenolate mofetil
Brand name: Cellcept, Myfortic, MMF
Synonyms: Mycophenolate mofetil (oral/injection), Mycophenolate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Mycophenolate Mofetil Tablets
- Insulin glargine and lixisenatide-Mycophenolate sodium
- Insulin glargine and lixisenatide-Mycophenolate Suspension
- Insulin glargine and lixisenatide-Mycophenolate Tablets
- Insulin glargine and lixisenatide-Mycophenolate Tablets Delayed Release
- Insulin glargine and lixisenatide-Mycophenolic acid
- Mycophenolate mofetil oral/injection-Insulin glargine and lixisenatide Subcutaneous
- Mycophenolate mofetil oral/injection-Insulin glargine, recombinant Subcutaneous
- Mycophenolate mofetil oral/injection-Insulin glulisine
- Mycophenolate mofetil oral/injection-Insulin Glulisine (Cartridges and Pens)
- Mycophenolate mofetil oral/injection-Insulin Glulisine (Vials)
- Mycophenolate mofetil oral/injection-Insulin glulisine Subcutaneous